Company intelligence / Profile preview

Lynk Diagnostics

Irvine, California, United Stateslynk2health.com ↗

Ownership: Private
Development stage: Commercial

Overview

Lynk Diagnostics provides rapid and comprehensive toxicology and blood testing with a focus on addiction care. Their proprietary software delivers real-time results and actionable insights to help prevent relapses. They are recognized for concierge-level service and educational resources for clinicians.

Therapeutic areas: Psychiatry
Modalities: Device (diagnostic testing)Software (real-time toxicology analytics)
Industry: Metabolite Diagnostics

Partnerships

Not specified in public sources; works closely with treatment centers, clinicians, and healthcare facilities.

Beyond the preview

Go deeper on Lynk Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lynk Diagnostics.

Explore the full profile